ArticleScientific reports2022

Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma.

Lei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.